FDA Inspection 1076076 — John Sleasman, MD

John Sleasman, MD — FEI 3014671661

The FDA completed an inspection of John Sleasman, MD on Dec 14, 2018 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 14, 2018
Fiscal Year
2019
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Durham, NC (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.